Report by the Economist Intelligence Unit supported by Janssen Governments across the world will have to face up to the challenges posed by the hepatitis C (HCV) pandemic or experience spiralling healthcare costs, says the Economist Intelligence Unit in its report The silent pandemic: Tackling hepatitis C with policy innovation. The report, made possible as a result of an educational grant from Janssen, challenges countries to use co-ordinated strategies to tackle HCV but warns that this will not be easy because few countries understand the magnitude of..
In the United States, Janssen has been recognized as the most productive pharmaceutical company of the last 10 years. Janssen, which is more known in the US under the name of its parent company Johnson & Johnson, appeared to have..
On 13 March, Johnson & Johnson announced the opening of the Johnson & Johnson Innovation centre in London. The goal of the London innovation centre is to accelerate the best early stage science in the world and advance the development..
Through our parent company Johnson & Johnson, Janssen is committed to help realise the United Nations Millennium Development Goals. This is a set of eight priorities the UN has..
The pharmaceutical business of Johnson & Johnson, known under the Janssen brand, has been named the most innovative global pharmaceutical firm by IDEA Pharma, an industry leading consultancy that annually ranks pharmaceutical companies based on their ability to bring new..
Jun
13
18th Congress of the European Hematology Association (EHA)
Stockholm, Sweden
Jun
21
Jun
30
7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013)
Kuala Lumpur, Malaysia